Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02527018 · ClinicalTrials.gov registry record
A Comparison of BNP Levels Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 66
- Enrollment target
NCT02527018 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 66 participants.
The verdict
NCT02527018 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
Primary Endpoint: Quantify the hemodynamic changes in preeclampsia using the non-invasive Nexfin device. Secondary Endpoint: Determine if measurable hemodynamic changes are statistically correlated with B-type natriuretic peptide (BNP) levels.
Interventions
- DEVICE Sphygmomanometer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2014-11 |
| Est. Completion | 2017-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02527018
The ClinicalTrials.gov registry entry for NCT02527018 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sphygmomanometer is the first listed.
NCT02527018 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02527018 about?
NCT02527018 is a clinical study titled "A Comparison of BNP Levels Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women". Primary Endpoint: Quantify the hemodynamic changes in preeclampsia using the non-invasive Nexfin device. Secondary Endpoint: Determine if measurable hemodynamic changes are statistically correlated with B-type natriuretic peptide (BNP) levels.
What is the current status of trial NCT02527018?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2014-11. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02527018?
The interventions under investigation include: Sphygmomanometer (DEVICE).
Who is sponsoring clinical trial NCT02527018?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.